Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Clinical trial NCT01598168 · TERMINATED
Trial details
- NCT number
- NCT01598168
- Sponsor
- McMaster University
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-07-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.